Age-related Changes in CMV-specific T Cells
Author Information
Author(s): Angelika Schwanninger, Birgit Weinberger, Daniela Weiskopf, Dietmar Herndler-Brandstetter, Stephan Reitinger, Christoph Gassner, Harald Schennach, Walther Parson, Reinhard Würzner, Beatrix Grubeck-Loebenstein
Primary Institution: Institute for Biomedical Aging Research, Austrian Academy of Sciences
Hypothesis
The study investigates the clonal composition of CMV-specific T cell responses in different age groups.
Conclusion
Older adults exhibit a specific high-avidity CD8+ T cell clonotype that is absent in younger individuals, which may help explain the lack of overt CMV disease in the elderly.
Supporting Evidence
- Older adults have a higher frequency of CMV-specific CD8+ T cells.
- A specific T cell clonotype appears in middle-aged and elderly donors but not in young individuals.
- The high avidity clonotype may provide better control of CMV infection.
Takeaway
As people get older, their immune system changes, and they develop a special type of immune cell that helps fight a common virus called CMV, which younger people don't have.
Methodology
CD8+ T cells were isolated from blood, stimulated with a CMV peptide, and analyzed for clonal composition and avidity.
Potential Biases
Potential selection bias due to the exclusion of individuals with certain health conditions.
Limitations
The study only included healthy donors and may not represent individuals with chronic diseases.
Participant Demographics
Participants included 10 young (≤39 years), 7 middle-aged (40-64 years), and 15 elderly (≥65 years) donors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website